3-Onium derivatives of 1,4-benzodiazepin-2-ones with tertiary organic bases.
D000818:Animals; D000927:Anticonvulsants / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D001570:Benzodiazepinones / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology; D004597:Electroshock; D066298:In Vitro Techniques; D007928:Lethal Dose 50; D008099:Liver / Q000378:metabolism; D009043:Motor Activity / Q000187:drug effects; D009125:Muscle Relaxants, Central / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D000644:Quaternary Ammonium Compounds / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology; D051381:Rats; D014149:Tranquilizing Agents / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology
D000927:Anticonvulsants; D001570:Benzodiazepinones; D009125:Muscle Relaxants, Central; D000644:Quaternary Ammonium Compounds; D014149:Tranquilizing Agents; D010433:Pentylenetetrazole